App Note: Easy Transfer of Your Traditional Western Blot to Wes
Wes™ builds on over a decade of Simple Western development and makes running a Western even more simple...
List view / Grid view
An assay is an analytical procedure in laboratory medicine, pharmacology and molecular biology for measuring the activity of a target entity.
Wes™ builds on over a decade of Simple Western development and makes running a Western even more simple...
Wes now analyzes proteins up to 440 kDa with the same Simple Western speed and data quality you’ve come to enjoy...
8 October 2015 | By Avacta Life Sciences
In this webinar we discuss Affimer® technology, a novel antibody mimetic and powerful antibody alternative...
Three major usability improvements are now available for the iCE3 system...
The Simple Western Immunoassay is the gel-free, blot-free and hands-free solution for those looking for a better way to get their Western blot data...
25 September 2015 | By Victoria White
The team of researchers will comprehensively study human proteomes with the aim of turning the vast amount of molecular information into designs for new reagents, equipment, workflows, assays and software...
The large family of pharmaceutical targets represented by G-protein coupled receptors (GPCRs) are usually involved in a number of intracellular effector pathways, leading to many cellular outcomes. In recent years it has been uncovered that different ligands of a given GPCR may engage the pathways selectively, in that ligands that…
21 September 2015 | By SomaLogic
The SOMAscan™ assay is a highly multiplexed, sensitive, quantitative and reproducible proteomic tool for discovering biomarkers for drug discovery...
21 September 2015 | By BioTek
The Synergy Neo2 Multi-Mode Reader is designed to provide high temporal resolution in drug target kinetics applications...
15 September 2015 | By IntelliCyt
Identification of antibodies against challenging targets using high throughput multiplex-screening approaches...
22 July 2015 | By Victoria White
Roche’s Elecsys immunoassay, a diagnostic test to detect antibodies against Human T-lymphotropic virus (HTLV) type I or II, is now available on the market...
8 July 2015 | By Victoria White
Douglas Scientific is sponsoring a Tumor Cell Profiling Study for up to three researchers as part of a collaborative partnership with TATAA Biocenter...
Find out about the science behind Affimers - including why Affimers are superior to antibodies and details about our custom Affimer process...
Find out more about the applications of Affimers, including how Affimers can be used in the development of therapeutics...
This video introduces Avacta Life Sciences, part of Avacta Group plc and its flagship product, Affimers - a revolutionary new, engineered alternative to antibodies...